Form 4: Dividend-Equivalent RSU Grant to PJT Board Member
Rhea-AI Filing Summary
PJT Partners Inc. (PJT) – SEC Form 4 filing dated 06/20/2025
Director James Costos reported the automatic acquisition of 15 restricted stock units (RSUs) on 06/18/2025. The transaction is coded “A,” indicating a grant rather than an open-market purchase, and carries a $0 exercise price because it represents dividend-equivalent rights that accrue and vest concurrently with the underlying RSUs. Following this modest grant, the director now holds 10,372 derivative securities (RSUs) on a direct basis. No common shares were bought or sold, and no dispositions occurred. The filing is a routine update of insider ownership under Section 16(a); it does not reflect any change in the company’s strategy, capital structure, or operating outlook.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small, zero-cost RSU grant; negligible valuation impact.
This Form 4 records a routine dividend-equivalent adjustment of 15 RSUs to Director James Costos. At PJT’s recent share price (~$100), the grant equates to roughly $1,500—immaterial relative to market cap and daily volume. Because it is non-cash, non-market, and vests with existing awards, it neither signals insider sentiment nor affects float. Investors should view the filing as standard administrative upkeep rather than a catalyst.
TL;DR: Governance-compliant dividend RSU credit; neutral.
The grant complies with PJT’s equity compensation plan and aligns director pay with shareholder returns via dividend equivalents. No red flags emerge: the award size is proportional, Form 4 is timely, and ownership remains clearly disclosed as direct (D). From a governance stance, this filing maintains transparency but offers no new insight into board sentiment or future policy.